查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541500

2024-2032 年按產品、技術、測試類型和地區分類的新生兒篩檢市場報告

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球新生兒篩檢市場規模達到 10.266 億美元。個人對早期發現新生兒嚴重疾病的意識不斷增強、醫療技術的進步以實現更準確的結果以及有利的政府舉措是推動市場成長的一些關鍵驅動力。

全球新生兒篩檢市場分析：

主要市場促進因素：代謝和遺傳疾病的日益普及以及出生率的提高主要推動了新生兒篩檢市場佔有率的成長。除此之外，對可降低醫療成本和改善結果的篩檢測試的需求不斷增加，也是另一個重要的成長誘導因素。

主要市場趨勢：資料管理和分析工具的不斷整合以提高新生兒篩檢的效率是支撐新生兒篩檢市場前景的新興趨勢之一。此外，父母對預防性醫療措施和整體福祉的日益重視進一步推動了新生兒篩檢市場需求。

地理趨勢：根據新生兒篩檢市場研究報告，由於擁有先進的醫療基礎設施，北美表現出明顯的主導地位。除此之外，有利的政府措施和法規正在進一步積極影響區域市場。

競爭格局：全球新生兒篩檢市場的一些主要參與者包括 Agilent Technologies Inc.、Baebies Inc.、Bio-RAD Laboratories Inc.、Chromsystems Instruments & Chemicals GmbH、Danaher Corporation、Masimo Corporation、Medtronic plc、Natus Medical Incorporated、 Perkinelmer Inc.、RECIPE Chemicals + Instruments GmbH、Thermo Fisher Scientific Inc.、Trivitron Healthcare 和Waters Corporation 等。

挑戰與機會：阻礙​​新生兒篩檢市場的主要挑戰之一是許多國家和地區的新生兒篩檢測試缺乏標準化。除此之外，法律和道德方面的考慮，包括資料隱私和同意，可能會為擴大和實施新生兒篩檢計畫帶來挑戰。然而，確保有效解決各種潛在健康問題的有利措施的推出預計將在預測期內擴大全球市場。

全球新生兒篩檢市場趨勢：

提高早期疾病檢測意識

父母越來越意識到早期疾病檢測的重要性，因為它有助於提高治療效果、改善兒童的生活品質、提供及時介入等，這是推動新生兒篩檢市場的主要驅動力之一。除此之外，先天性疾病發生率的上升也是另一個重要的生長誘導因素。例如，根據世界衛生組織2023年2月公佈的資料，全球每年估計有24萬名新生兒在出生後28天內因先天性疾病死亡。此外，根據印度兒科的訊息，印度每1,000名嬰兒中就有2.1人患有先天性甲狀腺功能減退症，先天性代謝異常的盛行率為2-7.8%。

有利的政府舉措

監管機構推出的政策通常涵蓋一系列全面的疾病，並確保有效解決潛在的健康問題，這正在提振全球新生兒篩檢市場。例如，2022 年 6 月，加拿大馬尼托巴省政府機構宣布擴大新生兒篩檢計劃，旨在擴大脊髓性肌肉萎縮症以及其他疾病的篩檢範圍。此外，各政府部門也強制新生兒出院前進行篩檢，進而對整體市場成長產生正面影響。例如，根據 2021 年的《March of Dimes》（MoD）報告，美國的每個嬰兒在離開醫院之前都經過了篩選過程。此外，德州、加州和紐約州的新生兒篩檢計畫也在美國各地獲得了廣泛關注，這將在預測期內繼續推動新生兒篩檢市場。

醫療科技的進步

主要參與者正在改進他們的醫療技術，以改善新生兒篩檢方法，這是另一個重要的生長誘導因素。此外，新興的篩檢技術鼓勵醫療保健提供者提供和​​採用這些服務，從而推動全球市場的發展。例如，2021 年 6 月，德州衛生與公眾服務部推出了新生兒脊髓性肌肉萎縮症 (SMA) 篩檢。為此，Trivitron Healthcare 在印度 AMTZ 園區建立了卓越中心 (CoE)，擁有最先進的研發和製造設施，用於基因組學、新生兒篩檢、代謝組學和分子診斷。此外，2023 年 1 月，Masimo 宣布推出全新的最先進的嬰兒監控系統，讓護理人員能夠即時監控嬰兒的資料。

全球新生兒篩檢市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、技術和測試類型對市場進行了分類。

按產品分類：

儀器儀表

試劑

儀器代表最大的細分市場

該報告根據產品提供了詳細的市場細分和分析。這包括儀器和試劑。報告顯示，儀器儀表佔據最大的市場佔有率。

儀器在樣本採集、分析、結果解釋等篩選過程中發揮至關重要的作用。此外，主要醫療保健公司對需要儀器的診斷測試的投資不斷增加，預計將推動這一細分市場的成長。例如，2023 年 3 月，GC Labs 宣布推出整合新疾病檢測方法的新測試，用於診斷新生兒先天性代謝錯誤 (IEM)。

按技術分類：

串聯質譜法

脈搏血氧儀

基於酵素的測定

DNA檢測

電泳

其他

串聯質譜佔據大部分市場佔有率

該報告基於該技術對市場進行了詳細的細分和分析。這包括串聯質譜法、脈搏血氧測定法、酵素測定法、DNA 測定法、電泳法等。報告稱，串聯質譜佔據了最大的市場佔有率。

串聯質譜法是指用於新生兒篩檢以識別多種代謝紊亂的分析技術。與此一致的是，它提供了更高的準確性和速度。醫療領域的眾多技術進步增強了串聯質譜分析技術，這將繼續推動該細分市場的成長。例如，2023年4月，沃特世公司宣布開發出用於臨床應用的新型Xevo TQ絕對IVD質譜儀。

按測試類型分類：

乾血斑測試

慢性心臟衰竭

聽力篩檢

乾血斑檢測佔最大市場佔有率

該報告根據測試類型提供了詳細的市場細分和分析。這包括乾血斑測試、CCHD 和聽力篩檢。報告稱，乾血斑檢測佔據最大的市場佔有率。

乾血斑測試是指一種非侵入性篩檢技術，通常涉及從新生兒腳跟收集少量血液到特殊濾紙上。然後分析乾燥的血液樣本中是否存在與多種疾病相關的特定標記。該測試在新生兒篩檢計畫中廣受青睞，因為它運輸方便、樣本採集方便，並且能夠同時篩檢各種情況。除此之外，政府機構的措施數量不斷增加是這一細分領域另一個重要的成長誘導因素。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的新生兒篩檢市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

北美先天性殘疾的盛行率不斷上升，增加了新生兒篩檢的需求。此外，該地區政府機構實施嚴格的法規也是另一個重要的成長誘導因素。例如，根據2021年的March of Dimes (MoD)報告，美國的每個嬰兒在離開醫院之前都經過了篩選過程。除此之外，主要參與者對預防性醫療保健的日益關注正在推動先進技術的普及，預計這將在可預見的未來提振北美新生兒篩檢市場。

競爭格局：

各製造商正在投資研發 (R&D) 活動，以提供創新的篩選技術和方法。這包括改進串聯質譜等現有技術，並探索新方法來擴大檢測條件的範圍。此外，公司還透過在測試組中添加更多條件來提供更全面的篩選服務。除此之外，主要參與者也專注於開發自動化系統，以簡化從樣本收集到結果解釋的篩選過程，以提高效率、減少人為錯誤並縮短週轉時間。

市場研究報告對競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

安捷倫科技公司

寶貝公司

Bio-RAD 實驗室公司

Chromsystems 儀器與化學品有限公司

丹納赫公司

馬西莫公司

美敦力公司

內特斯醫療公司

珀金內爾默公司

RECIPE 化學品+儀器有限公司

賽默飛世爾科技公司

Trivitron 醫療保健

沃特世公司

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

全球新生兒篩檢市場新聞：

2024 年 3 月：世界衛生組織 (WHO) 在東南亞推出了針對新生兒眼部異常、聽力障礙和新生兒黃疸進行普遍篩檢的實施指南。

2024 年 2 月：海得拉巴的 Niloufer 醫院推出了一項新生兒篩檢計劃，以檢測罕見的遺傳狀況。

2024 年2 月：一項名為「早期檢查」的研究對1,000 名出生後的新生兒進行了篩檢，以提供治療、向父母提供教育資訊、及早發現罕見疾病，並將家庭與整個北卡羅來納州的專家聯繫起來。

本報告回答的關鍵問題

  • 2023年全球新生兒篩檢市場規模有多大
  • 2024-2032年全球新生兒篩檢市場的預期成長率是多少
  • 推動全球新生兒篩檢市場的關鍵因素是什麼
  • COVID-19 對全球新生兒篩檢市場有何影響
  • 基於產品的全球新生兒篩檢市場區隔是怎樣的
  • 基於該技術的全球新生兒篩檢市場的細分如何
  • 根據測試類型，全球新生兒篩檢市場的細分如何
  • 全球新生兒篩檢市場的重點區域有哪些
  • 誰是全球新生兒篩檢市場的主要參與者/公司

本報告回答的關鍵問題

  • 2023年全球新生兒篩檢市場規模有多大？ 2024-2032年全球新生兒篩檢市場的預期成長率是多少？
  • 推動全球新生兒篩檢市場的關鍵因素是什麼？
  • COVID-19 對全球新生兒篩檢市場有何影響？
  • 基於產品的全球新生兒篩檢市場的詳細情形如何？
  • 基於該技術的全球新生兒篩檢市場的詳細情形如何？
  • 根據測試類型，全球新生兒篩檢市場的細分如何？
  • 全球新生兒篩檢市場的重點區域有哪些？
  • 全球新生兒篩檢市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球新生兒篩檢市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 儀器儀表
    • 市場趨勢
    • 市場預測
  • 試劑
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依技術

  • 串聯質譜法
    • 市場趨勢
    • 市場預測
  • 脈搏血氧儀
    • 市場趨勢
    • 市場預測
  • 基於酵素的測定
    • 市場趨勢
    • 市場預測
  • DNA檢測
    • 市場趨勢
    • 市場預測
  • 電泳
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按測試類型

  • 乾血斑測試
    • 市場趨勢
    • 市場預測
  • 慢性心臟衰竭
    • 市場趨勢
    • 市場預測
  • 聽力篩檢
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Baebies Inc.
    • Bio-RAD Laboratories Inc.
    • Chromsystems Instruments & Chemicals GmbH
    • Danaher Corporation
    • Masimo Corporation
    • Medtronic plc
    • Natus Medical Incorporated
    • Perkinelmer Inc.
    • RECIPE Chemicals + Instruments GmbH
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
    • Waters Corporation
Product Code: SR112024A4068

The global newborn screening market size reached US$ 1,026.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,777.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The increasing awareness among individuals towards early detection of severe diseases in newborns, improvements in medical technology for more accurate outcomes, and favorable government initiatives represent some of the key drivers bolstering the market growth.

Global Newborn Screening Market Analysis:

Major Market Drivers: The growing prevalence of metabolic and genetic disorders and the increasing birth rates are primarily driving the newborn screening market share. Apart from this, the escalating demand for screening tests that provide reduced healthcare costs and improved outcomes is also acting as another significant growth-inducing factor.

Key Market Trends: The rising integration of data management and analysis tools to improve the efficiency of newborn screening is one of the emerging trends bolstering the newborn screening market outlook. Additionally, the inflating emphasis on preventive healthcare measures and holistic well-being among parents is further propelling the newborn screening market demand.

Geographical Trends: According to the newborn screening market research report, North America exhibits a clear dominance, owing to the presence of advanced healthcare infrastructures. Besides this, favorable government initiatives and regulations are further positively influencing the regional market.

Competitive Landscape: Some of the key players in the global newborn screening market include Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation, among many others.

Challenges and Opportunities: One of the primary challenges hindering the newborn screening market is the lack of standardization in newborn screening tests across numerous countries and regions. Besides this, legal and ethical considerations, including data privacy and consent, can pose challenges in expanding and implementing newborn screening programs. However, the launch of favorable initiatives that ensure that a wide range of potential health issues are addressed efficiently is projected to augment the global market over the forecasted period.

Global Newborn Screening Market Trends:

Increasing Awareness about Early Disease Detection

The growing awareness among parents towards the critical importance of early disease detection, as it helps in enhancing treatment outcomes, improving quality of life for the child, offering timely intervention, etc., represents one of the primary drivers bolstering the newborn screening market. Besides this, the rising occurrence of congenital diseases is also acting as another significant growth-inducing factor. For example, according to the data published by the WHO in February 2023, an estimated 240,000 newborns die within 28 days of birth each year globally due to congenital diseases. Moreover, according to the information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2-7.8%.

Favorable Government Initiatives

The launch of policies by regulatory authorities that often cover a comprehensive panel of disorders and ensure that potential health issues are addressed efficiently is bolstering the global newborn screening market. For example, in June 2022, government bodies in Manitoba, Canada, announced the expansion of their newborn screening program with an aim to extend screening for spinal muscular atrophy, along with other diseases. Moreover, various government authorities have also made newborn screening compulsory before getting discharged from the hospital, thereby positively impacting the overall market growth. For instance, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Furthermore, newborn screening programs in Texas, California, and New York also gained extensive traction across the U.S., which will continue to drive the newborn screening market over the forecasted period.

Improvements in Medical Technology

Key players are advancing their medical technologies to improve newborn screening methods, which is acting as another significant growth-inducing factor. Moreover, emerging screening technologies encourage healthcare providers to offer and adopt these services, thereby fueling the global market. For example, in June 2021, the Texas Health and Human Services introduced newborn screening for Spinal Muscular Atrophy (SMA). In line with this, Trivitron Healthcare developed a Centre of Excellence (CoE) with state-of-the-art R&D and manufacturing facilities at AMTZ Campus in India for genomics, newborn screening, metabolomics, and molecular diagnostics. Furthermore, in January 2023, Masimo announced the launch of its new state-of-the-art baby monitoring system that allows caretakers to monitor the data of babies in real-time.

Global Newborn Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology and test type.

Breakup by Product:

Instruments

Reagents

Instruments represent the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments and reagents. According to the report, instruments accounted for the largest market share.

Instruments play a crucial role in the screening process for sample collection, analysis, result interpretation, etc. In addition to this, they comprise a wide array of technologies, such as deoxyribonucleic acid (DNA) analyzers, automated screening platforms, mass spectrometry systems, etc. Moreover, the rising investments by key healthcare companies in diagnostics tests that require instruments are expected to bolster the market growth in this segmentation. For instance, in March 2023, GC Labs announced the launch of its new test for the diagnosis of Inborn Errors of Metabolism (IEM) among newborns with the integration of novel disease detection methods.

Breakup by Technology:

Tandem Mass Spectrometry

Pulse Oximetry

Enzyme Based Assay

DNA Assay

Electrophoresis

Others

Tandem mass spectrometry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others. According to the report, tandem mass spectrometry accounted for the largest market share.

Tandem mass spectrometry refers to an analytical technique that is employed in newborn screening to identify several metabolic disorders. In line with this, it provides improved accuracy and speed. Numerous technological advancements in the medical field enhance tandem mass spectrometry, which will continue to drive the market growth in this segmentation. For example, in April 2023, Waters Corporation announced the development of its new Xevo TQ Absolute IVD Mass Spectrometer for clinical applications.

Breakup by Test Type:

Dry Blood Spot Test

CCHD

Hearing Screen

Dry blood spot test holds the biggest market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes dry blood spot test, CCHD, and hearing screen. According to the report, the dry blood spot test accounted for the largest market share.

A dry blood spot test refers to a non-invasive screening technique that generally involves collecting a small amount of blood from the heel of a newborn onto a special filter paper. The dried blood sample is then analyzed for the presence of specific markers associated with several disorders. The test is widely preferred among newborn screening programs, as it provides ease of transportation, convenience of sample collection, and the ability to simultaneously screen for various conditions. Besides this, the elevating number of initiatives by government bodies is acting as another significant growth-inducing factor in this segmentation.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest newborn screening market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing prevalence of congenital disabilities in North America is augmenting the need for newborn screening. Moreover, the implementation of stringent regulations by government bodies across the region is also acting as another significant growth-inducing factor. For example, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Apart from this, the elevating focus of key players on preventive healthcare is inflating the popularity of advanced technologies, which is expected to bolster the North America newborn screening market over the foreseeable future.

Competitive Landscape:

Various manufacturers are investing in research and development (R&D) activities to provide innovative screening technologies and methods. This includes refining existing techniques like tandem mass spectrometry and exploring new approaches to broaden the scope of conditions detected. In addition, companies are providing a more comprehensive screening service by adding more conditions to their test panels. Apart from this, key players are also focusing on developing automated systems that streamline the screening process, from sample collection to result interpretation, to enhance efficiency, reduce human error, and allow for faster turnaround times.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Baebies Inc.

Bio-RAD Laboratories Inc.

Chromsystems Instruments & Chemicals GmbH

Danaher Corporation

Masimo Corporation

Medtronic plc

Natus Medical Incorporated

Perkinelmer Inc.

RECIPE Chemicals + Instruments GmbH

Thermo Fisher Scientific Inc.

Trivitron Healthcare

Waters Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Global Newborn Screening Market News:

March 2024: The World Health Organization (WHO) launched implementation guidance in Southeast Asia for universal screening of eye abnormalities, hearing impairment, and neonatal jaundice among newborns.

February 2024: Niloufer Hospital in Hyderabad introduced a newborn screening program to detect rare genetic conditions.

February 2024: A research study titled Early Check has screened 1,000 newborns after birth to provide treatment, give parents educational information, identify rare conditions early, and connect families with specialists throughout the state of North Carolina.

Key Questions Answered in This Report

  • 1. What was the size of the global newborn screening market in 2023?
  • 2. What is the expected growth rate of the global newborn screening market during 2024-2032?
  • 3. What are the key factors driving the global newborn screening market?
  • 4. What has been the impact of COVID-19 on the global newborn screening market?
  • 5. What is the breakup of the global newborn screening market based on the product?
  • 6. What is the breakup of the global newborn screening market based on the technology?
  • 7. What is the breakup of the global newborn screening market based on the test type?
  • 8. What are the key regions in the global newborn screening market?
  • 9. Who are the key players/companies in the global newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Newborn Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pulse Oximetry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Enzyme Based Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Assay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Electrophoresis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CCHD
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hearing Screen
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baebies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Chromsystems Instruments & Chemicals GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Masimo Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Natus Medical Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Perkinelmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 RECIPE Chemicals + Instruments GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Trivitron Healthcare
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2023
  • Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Newborn Screening Industry: SWOT Analysis
  • Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
  • Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Newborn Screening Market: Competitive Structure
  • Table 7: Global: Newborn Screening Market: Key Players